Skip to main content

Articles

Page 11 of 12

  1. To assess the impact of reference pricing and extension of generic substitution on the daily cost of antipsychotic drugs in Finland during the first year after its launch. Furthermore, the additional impact of...

    Authors: Hanna Koskinen, Elina Ahola, Leena K Saastamoinen, Hennamari Mikkola and Jaana E Martikainen
    Citation: Health Economics Review 2014 4:9
  2. In Switzerland, age is the predominant driver of solidarity transfers in risk adjustment (RA). Concerns have been voiced regarding growing imbalances in cost sharing between young and old insured due to demogr...

    Authors: Viktor von Wyl and Konstantin Beck
    Citation: Health Economics Review 2014 4:7
  3. While induced abortion is considered to be illegal and socially unacceptable in Nigeria, it is still practiced by many women in the country. Poor family planning and unsafe abortion practices have daunting eff...

    Authors: Bosede O Awoyemi and Jacob Novignon
    Citation: Health Economics Review 2014 4:3
  4. To identify associations between market factors, especially relative reimbursement rates, and the probability of surgery and cost per episode for three medical conditions (cataract, benign prostatic neoplasm, ...

    Authors: Jack Hadley, James D Reschovsky, James A O’Malley and Bruce E Landon
    Citation: Health Economics Review 2014 4:8
  5. In the majority of children and adolescents with epilepsy, optimal drug therapy adequately controls their condition. However, among the remaining patients who are still uncontrolled despite mono-, bi- or tri-t...

    Authors: Dawn C Lee, Daniel Gladwell, Anthony J Hatswell, Joshua Porter, Nic Brereton, Elaine Tate and Alison L Saunders
    Citation: Health Economics Review 2014 4:6
  6. The prospective reimbursement of hospitals through the grouping of patients into a finite number of categories (Diagnosis Related Groups, DRGs), is common to many European countries. However, the specific cate...

    Authors: James Gaughan and Conrad Kobel
    Citation: Health Economics Review 2014 4:4
  7. The German AMNOG healthcare reform includes a mandatory early-benefit-assessment (EBA) at launch. As per German social code, EBA is based on registration trials and includes evaluation of the patient-relevant ...

    Authors: Inna Dabisch, Jürgen Dethling, Charalabos-Markos Dintsios, Melanie Drechsler, Daniel Kalanovic, Peter Kaskel, Frank Langer, Jörg Ruof, Thorsten Ruppert and Daniel Wirth
    Citation: Health Economics Review 2014 4:2
  8. Care of stroke patients costs considerably more in specialized stroke units (SU) compared to care in general medical wards (GMW) but the technology may be cost effective if it leads to significantly improved o...

    Authors: Farasat AS Bokhari, Ian Wellwood, Anthony G Rudd, Peter Langhorne, Martin S Dennis and Charles DA Wolfe
    Citation: Health Economics Review 2014 4:1
  9. In April 2008, specialization in gynecology and obstetrics departments was introduced in the Sennan area of Osaka prefecture in Japan that aimed at solving the problems of regional provisions of obstetrics ser...

    Authors: Yoshimi Adachi, Hiroyasu Iso, Junyi Shen, Kanami Ban, On Fukui, Hiroyuki Hashimoto, Takako Nakashima, Kenichiro Morishige and Tatuyoshi Saijo
    Citation: Health Economics Review 2013 3:31
  10. Patient-centered health care and shared decision making are of increasing importance in the management of AIDS/HIV patients and require an intensive consideration of patient preferences. The present study asse...

    Authors: Axel C Mühlbacher, Matthias Stoll, Jörg Mahlich and Matthias Nübling
    Citation: Health Economics Review 2013 3:30
  11. Recently the sequencing of the human genome has become a major biological and clinical research field. However, the public health impact of this new technology with focus on the financial effect is not yet to ...

    Authors: Martin Frank, Anne Prenzler, Roland Eils and J-Matthias Graf von der Schulenburg
    Citation: Health Economics Review 2013 3:29
  12. The objective of the study was to analyse whether azacitidine is a cost-effective option for the treatment of myelodysplastic syndrome in the Spanish setting compared with conventional care regimens, including...

    Authors: Carlos Crespo, Estela Moreno, Jordi Sierra, Suzan Serip and Marta Rubio
    Citation: Health Economics Review 2013 3:28
  13. Rotavirus gastroenteritis (RVGE) is a frequent disease in young children. The recommended German paediatric immunisation schedule does not currently include rotavirus vaccination. A lack of economic data on th...

    Authors: Stefanie Knoll, Christoph Mair, Ursula Benter, Katja Vouk and Baudouin Standaert
    Citation: Health Economics Review 2013 3:27
  14. Respiratory syncytial virus (RSV) is a common cause of respiratory infection that is highly prevalent in infants. Severe cases of RSV infection require hospitalisation; this is most likely to occur in infant p...

    Authors: Anthony Bentley, Ivana Filipovic, Katherine Gooch and Katharina Büsch
    Citation: Health Economics Review 2013 3:18
  15. Fingolimod is an innovative drug with a significant budget impact in the treatment of MS in Spain. The aim of this study was to calculate the direct cost comparison of glatiramer acetate and fingolimod for the...

    Authors: Rainel Sanchez-de la Rosa, Eliazar Sabater and Miguel A Casado
    Citation: Health Economics Review 2013 3:13
  16. The reliance on out-of-pocket payments for health services leads to a catastrophic burden for many households in Bangladesh. The World Health Organization suggests that risk-pooling mechanisms should be used f...

    Authors: Jahangir AM Khan and Sayem Ahmed
    Citation: Health Economics Review 2013 3:12
  17. The increasing prevalence of diabetes and its inadequate management results in a heavy burden of the disease for the patients, the health and the productive system and the overall community. Consequently, it i...

    Authors: Jorge F Elgart, Joaquin E Caporale, Lorena Gonzalez, Eleonora Aiello, Maximiliano Waschbusch and Juan J Gagliardino
    Citation: Health Economics Review 2013 3:11
  18. Myocardial infarction networks have been shown to improve guideline adherent therapy and outcomes in patients presenting with acute ST-elevation myocardial infarction (STEMI). Our objective was to assess the s...

    Authors: Ralf Birkemeyer, Anke Dauch, Alfred Müller, Manfred Beck, Henrik Schneider, Hueseyin Ince, Werner Jung and Steffen Wahler
    Citation: Health Economics Review 2013 3:10
  19. In contrast to other countries, surgery still represents the common invasive treatment for varicose veins in Germany. However, radiofrequency ablation, e.g. ClosureFast, becomes more and more popular in other ...

    Authors: Alexander Kuhlmann, Anne Prenzler, Jan Hacker and J-Matthias Graf von der Schulenburg
    Citation: Health Economics Review 2013 3:9
  20. Common approaches in cost-effectiveness analyses do not adjust for confounders. In nonrandomized studies this can result in biased results. Parametric models such as regression models are commonly applied to a...

    Authors: Tommi Härkänen, Timo Maljanen, Olavi Lindfors, Esa Virtala and Paul Knekt
    Citation: Health Economics Review 2013 3:8
  21. To examine the impact of temporary and permanent weight loss of 10% and 15% on 10-year and lifetime Medicare spending among adults with overweight and obesity aged 65 years and older. Weight loss of this magni...

    Authors: Kenneth E Thorpe, Zhou Yang, Kathleen M Long and W Timothy Garvey
    Citation: Health Economics Review 2013 3:7
  22. This study aimed to apply the previously validated severity index for rheumatoid arthritis (SIFRA) to prevalent rheumatoid arthritis (RA) groups in Turkey and determine the effect of RA severity on health care...

    Authors: Onur Baser, Erdem Baser, Akif Altinbas and Abdulkadir Burkan
    Citation: Health Economics Review 2013 3:5
  23. Icatibant is the only subcutaneous treatment for acute Type I and Type II hereditary angioedema with C1-esterase inhibitor deficiency (HAE-C1-INH) licensed for self-administration in Europe.

    Authors: Antonio J Blasco, Pablo Lázaro, Teresa Caballero and Mar Guilarte
    Citation: Health Economics Review 2013 3:2
  24. Health care expenditure has been low over the years in developing regions of the world. A majority of countries in these regions, especially sub-Saharan Africa (SSA), rely on donor grants and loans to finance ...

    Authors: Jacob Novignon, Solomon A Olakojo and Justice Nonvignon
    Citation: Health Economics Review 2012 2:22
  25. To obtain detailed real-life data on costs and dosing patterns in the utilisation of the TNF inhibitors adalimumab, etanercept, and infliximab in patients treated in Switzerland.

    Authors: Jan Zeidler, Thomas Mittendorf, Rüdiger Müller and Johannes von Kempis
    Citation: Health Economics Review 2012 2:20
  26. Persistent infections with human papillomavirus (HPV) are a necessary cause of cervical cancer and are responsible for important morbidity in men and women. Since 2007, HPV vaccination has been recommended and...

    Authors: Deniz Schobert, Vanessa Remy and Oliver Schoeffski
    Citation: Health Economics Review 2012 2:19

Annual Journal Metrics

  • Citation Impact 2023
    Journal Impact Factor: 2.7
    5-year Journal Impact Factor: 2.8
    Source Normalized Impact per Paper (SNIP): 1.218
    SCImago Journal Rank (SJR): 0.800

    Speed 2023
    Submission to first editorial decision (median days): 7
    Submission to acceptance (median days): 220

    Usage 2023
    Downloads: 566,888
    Altmetric mentions: 483